Preliminary NICE ‘no’ for Takeda’s Alunbrig

3rd October 2018 Uncategorised 0

Draft guidelines from the National Institute for Health and Care Excellence do not recommend NHS funding for Takeda’s lung cancer drug Alunbrig.

More: Preliminary NICE ‘no’ for Takeda’s Alunbrig
Source: News